BAC Water with PT-141 and MT-2: Reconstitution Guide for Melanocortin Research Peptides
Research Notice: This article covers research topics relevant to BAC Water — available from Palmetto Peptides for laboratory use only.
DISCLAIMER: This article is for educational and scientific research reference purposes only. All compounds discussed are not approved by the FDA for use in humans or animals. All data discussed here reflects preclinical animal research or laboratory use. Palmetto Peptides sells these compounds exclusively for in vitro and preclinical laboratory research. Nothing in this article constitutes medical advice.
BAC Water with PT-141 and MT-2: Reconstitution Guide for Melanocortin Research Peptides
Last Updated: May 18, 2026 | Reading Time: Approximately 10 minutes | Author: Palmetto Peptides Research Team
Quick Answer
PT-141 (bremelanotide) and MT-2 (melanotan II) are cyclic peptide analogs of alpha-melanocyte-stimulating hormone (alpha-MSH) that act at melanocortin receptors and are studied in preclinical research examining pigmentation biology, energy homeostasis, and appetite regulation, among other systems. Both compounds are light-sensitive and must be handled under low-light conditions throughout reconstitution and storage. Bacteriostatic water is the appropriate reconstitution vehicle for both, and reconstituted solutions must be stored in amber or light-protected vials at 2 to 8 degrees Celsius.
Introduction: Melanocortin Receptor Research and These Two Peptides
The melanocortin system is one of the most pleiotropic signaling networks in mammalian biology. The five melanocortin receptors — MC1R through MC5R — are distributed across diverse tissue types and regulate a remarkable array of physiological processes: skin pigmentation (MC1R), adrenal steroidogenesis (MC2R), energy homeostasis and inflammation (MC3R and MC4R), and exocrine gland function (MC5R). Research into melanocortin signaling therefore spans from dermatology to metabolic biology to reproductive physiology.
Two synthetic cyclic peptide analogs have become central research tools in this field: PT-141 (bremelanotide, the deaminated form of Melanotan II) and MT-2 (melanotan II itself). Both are derived from alpha-MSH and share the core pharmacophore responsible for melanocortin receptor activation, but they differ in subtle structural ways that affect their receptor selectivity profiles and pharmacokinetic behavior in animal models. Understanding these differences is important for researchers designing studies and for making appropriate reconstitution decisions.
This guide covers the specific reconstitution requirements for both PT-141 and MT-2 using BAC water, with particular attention to the compounds' light sensitivity, which is the most critical handling consideration that distinguishes these melanocortin peptides from many other research compounds.
PT-141 and MT-2: Structural Background
Melanotan II (MT-2): The Parent Compound
MT-2 is a cyclic heptapeptide (Ac-Nle4-c[Asp5, D-Phe7, Lys10]-alpha-MSH(4-10)-NH2) with a molecular weight of approximately 1024 Da. The cyclic structure — formed by a lactam bridge between the aspartate and lysine residues — significantly enhances the peptide's proteolytic stability compared to linear MSH analogs. This was one of the primary motivations for its design: to create an alpha-MSH analog resistant to rapid enzymatic degradation in biological systems.
MT-2 activates multiple melanocortin receptor subtypes, with documented affinity for MC1R, MC3R, MC4R, and MC5R in binding studies. Its broad receptor activation profile makes it useful for research examining the melanocortin system as a whole, but complicates the attribution of specific effects to individual receptor subtypes — a consideration that should inform study design.
PT-141 (Bremelanotide): The Deaminated Analog
PT-141 is structurally similar to MT-2 but lacks the acetyl group on the N-terminal asparagine; it is instead a beta-amino acid-modified derivative of the same core pharmacophore. With a molecular weight of approximately 1025 Da, PT-141 is nearly identical in size to MT-2. In preclinical studies, PT-141 has shown similar broad melanocortin receptor engagement to MT-2, with research interest particularly focused on its interactions with MC4R in central nervous system tissue contexts.
It is worth noting that PT-141 (bremelanotide) received FDA approval in 2019 as Vyleesi for a specific indication. However, the research-grade PT-141 supplied by Palmetto Peptides is sold exclusively for in vitro and preclinical laboratory research and is categorically distinct from any approved pharmaceutical product. No product sold by Palmetto Peptides is for human use.
Key Structural Comparison
| Property | MT-2 (Melanotan II) | PT-141 (Bremelanotide) |
|---|---|---|
| Molecular weight (approx.) | ~1024 Da | ~1025 Da |
| Structure | Cyclic heptapeptide | Cyclic heptapeptide (deaminated) |
| Primary receptor targets in research | MC1R, MC3R, MC4R, MC5R | MC3R, MC4R (primary focus) |
| Light sensitivity | High — protect from light | High — protect from light |
| Aqueous solubility | Good in BAC water | Good in BAC water |
| Typical stock concentration | 1.0 to 2.0 mg/mL | 1.0 to 2.0 mg/mL |
| Storage after reconstitution | 2-8°C, light-protected | 2-8°C, light-protected |
Light Sensitivity: The Critical Handling Requirement
Why These Peptides Are Light-Sensitive
Both MT-2 and PT-141 contain phenylalanine residues (specifically D-phenylalanine in the 7-position), and the core pharmacophore includes a tryptophan-adjacent histidine in the MSH sequence. More relevantly, melanocortin peptides interact with UV-absorbing chromophores in their structure that make them susceptible to photochemical degradation. Exposure to UV light or prolonged exposure to bright visible light can cause photo-oxidation, racemization, or cross-linking reactions that alter the peptide's structure and compromise its biological activity in research models.
The lyophilized powder forms are somewhat more light-stable than the reconstituted solutions, because UV-driven photo-reactions typically require water as a medium. However, even the dry powder should be stored protected from direct light exposure. Once reconstituted, the solutions are significantly more light-sensitive and require active protection at all times.
Practical Light Protection Measures
Researchers working with MT-2 and PT-141 should implement the following light protection practices throughout the reconstitution and storage workflow. Use amber glass vials rather than clear glass vials for reconstitution and storage — the amber glass filters UV wavelengths that drive photo-degradation. If amber vials are not available, clear glass vials can be wrapped in aluminum foil to achieve similar protection. During the reconstitution process itself, minimize time under direct overhead laboratory lighting — this is best achieved by working efficiently and covering the vials with a small piece of foil between steps.
Avoid prolonged exposure to window light, which contains significant UV content. Store all reconstituted MT-2 and PT-141 preparations in the back of a refrigerator shelf, away from the door where light from the refrigerator lamp (if present) may reach the vials during door openings. These precautions are somewhat more stringent than those required for less light-sensitive peptides like ipamorelin or selank, but they are essential for maintaining the research integrity of melanocortin peptide preparations.
BAC Water Compatibility with MT-2 and PT-141
Chemical Compatibility
Bacteriostatic water is chemically compatible with both MT-2 and PT-141. The 0.9% benzyl alcohol preservative does not react with the cyclic peptide structures, the D-phenylalanine residues, or the lactam bridge that gives these compounds their cyclic geometry. The mildly acidic to neutral pH of most BAC water preparations (4.5 to 7.0) is within the acceptable stability window for both compounds.
Both MT-2 and PT-141 dissolve readily in BAC water without requiring organic co-solvents. Their moderate molecular weights (~1024 Da) and the balanced hydrophilic/hydrophobic character of the cyclic peptide scaffold allow complete dissolution in aqueous vehicles within minutes of gentle agitation.
Multi-Dose Research Protocol Requirements
As with other research peptides, the primary practical advantage of BAC water over sterile water for MT-2 and PT-141 research is the ability to maintain a single reconstituted preparation across multiple days of a study without contamination risk. Melanocortin receptor research protocols often involve repeated administration in rodent models to establish dose-response relationships or to assess cumulative biological effects, making bacteriostatic preservation essential. For a comparison of BAC water versus sterile water across peptide classes, see our reference article on BAC water vs. sterile water for peptide reconstitution.
Reconstitution Protocol for MT-2 and PT-141
Pre-Reconstitution Preparation
Before beginning reconstitution, gather all materials and prepare your workspace to minimize time with uncovered vials. You will need: lyophilized MT-2 or PT-141 (in its original sealed vial), bacteriostatic water, sterile syringes and needles, alcohol swabs, an amber glass vial (or aluminum foil for vial wrapping), and a calculator for concentration verification. Dim overhead lighting if possible, or position yourself away from direct light sources before opening vial packaging.
Reconstitution Steps
Allow both the lyophilized peptide vial and the BAC water vial to reach room temperature. Swab the septum of the lyophilized peptide vial with an alcohol swab and allow 30 seconds for the alcohol to evaporate. Draw the calculated volume of BAC water into a sterile syringe. Insert the needle into the peptide vial at a 45-degree angle. Add the BAC water slowly along the glass wall of the vial — do not forcefully squirt the water stream directly onto the lyophilized peptide cake. Gently swirl the vial (do not shake) until the peptide cake is fully dissolved. Both MT-2 and PT-141 typically dissolve within two to three minutes of gentle swirling.
Once dissolved, the solution should appear clear and colorless. If dissolution is incomplete after five minutes of gentle agitation, allow the vial to stand at room temperature for an additional five minutes before attempting further gentle swirling. Immediately after reconstitution, transfer the vial to an amber container or wrap in aluminum foil and move to refrigerated storage.
Concentration Ranges for Research Protocols
For MT-2 and PT-141, stock solution concentrations of 1.0 to 2.0 mg/mL in BAC water are most commonly reported in the preclinical research literature. This concentration range is appropriate for most animal model subcutaneous or intraperitoneal dosing protocols. For in vitro receptor binding studies or cell-based assays, the stock solution will typically be diluted by several orders of magnitude into the assay medium — benzyl alcohol dilution factor must be verified to ensure it falls below cytotoxic or pharmacologically active concentrations in the cell-based assay.
For detailed guidance on reconstitution volume calculations and working concentration preparation, see our reference article on BAC water concentration calculations for peptide research.
Research Applications: Melanocortin Receptor Biology
Pigmentation Research with MC1R
MT-2 has been more extensively used than PT-141 in pigmentation research models because of its higher affinity for MC1R, the primary melanocortin receptor expressed on melanocytes. Studies using MT-2 in rodent models have examined eumelanin production, melanocyte proliferation and differentiation, and UV-protective pigmentation responses. In vitro studies using cultured melanocyte cell lines have characterized dose-response relationships for MC1R-mediated cAMP accumulation and downstream tyrosinase activation — the rate-limiting enzyme in melanin synthesis.
Energy Balance and Appetite Research with MC3R/MC4R
Both MC3R and MC4R are expressed in the hypothalamus and play important roles in the central regulation of energy homeostasis and appetite. Research using both MT-2 and PT-141 in rodent models has examined food intake suppression, body weight changes, and metabolic rate parameters in response to melanocortin receptor activation. MC4R in particular has attracted significant research interest as a potential target in obesity-related research, and both MT-2 and PT-141 have been used as pharmacological tools to study MC4R-mediated signaling in hypothalamic circuits.
Comparative Research Utility
One practical distinction between MT-2 and PT-141 in research settings is receptor selectivity. Researchers who want to attribute observed effects specifically to MC4R engagement may prefer PT-141 over MT-2 in certain experimental designs, because PT-141's slightly different receptor engagement profile can help in comparing results against MC4R-selective agonists or antagonists. Researchers designing experiments to disentangle MC1R (pigmentation) effects from MC4R (central) effects will also need to carefully consider which compound, and at what concentration, best serves their specific experimental question.
For researchers comparing melanocortin peptides to other BAC water-reconstituted research compounds, our guides on Selank and Semax reconstitution and CJC-1295 and Ipamorelin reconstitution provide useful comparative context for handling different classes of research peptides.
Storage Conditions and Stability
Recommended Storage for Reconstituted MT-2 and PT-141
Reconstituted MT-2 and PT-141 in BAC water should be stored at 2 to 8 degrees Celsius, in amber glass vials or aluminum foil-wrapped clear vials, in the back of the refrigerator where light exposure from door openings is minimized. Under these conditions, the solutions are generally considered appropriate for research use for up to 28 to 30 days, though the exact stability window for any specific lot should be validated against the certificate of analysis data.
Lyophilized MT-2 and PT-141 prior to reconstitution should be stored at -20 degrees Celsius or below, in light-protected conditions. Once the lyophilized vial has been opened and reconstituted, it cannot be re-lyophilized in a standard laboratory setting. This makes careful planning of reconstitution volumes important — reconstitute only as much as will be used within the intended study period.
Aliquoting for Long-Term Studies
For research programs that will use MT-2 or PT-141 beyond the 28 to 30 day refrigerated stability window, aliquoting at the time of reconstitution is recommended. Divide the total reconstituted volume into single-study-session portions in amber glass vials or foil-wrapped clear vials. Store all aliquots at -20 to -80 degrees Celsius. Thaw each aliquot immediately before use, allow to reach room temperature, and use promptly. Do not refreeze thawed aliquots.
For comprehensive guidance on aliquoting strategies, freeze-thaw considerations, and shelf life maximization for research peptides in BAC water, see our detailed reference article on BAC water storage and shelf life for research labs.
Contamination Prevention for Melanocortin Peptide Preparations
The light protection requirements for MT-2 and PT-141 add one layer of complexity to contamination prevention, because they discourage leaving vials uncovered — which is already good contamination prevention practice. The two requirements (light protection and sterile technique) align well: keeping vials covered with amber glass or foil also prevents environmental dust and airborne microorganisms from settling on the septum area between uses. Always swab the septum with a fresh alcohol swab before each needle insertion, use a new sterile needle and syringe for each withdrawal, and inspect the solution for any change in color or clarity before each use. For full contamination prevention protocols, see our guide on BAC water contamination prevention for research labs.
Frequently Asked Questions
What makes MT-2 and PT-141 more light-sensitive than other research peptides?
Both MT-2 and PT-141 contain UV-absorbing amino acid residues and a cyclic peptide geometry with chromophore-adjacent residues that are susceptible to photo-oxidation and photo-chemical cross-linking reactions. When exposed to UV or prolonged visible light, the peptide structure can be modified in ways that alter receptor binding and biological activity in research models, compromising experimental validity.
Can MT-2 and PT-141 be reconstituted at the same time and combined?
Both compounds are soluble in BAC water and can be reconstituted using the same protocol. Combining them in the same solution is technically feasible — the two cyclic peptides do not react covalently with each other under aqueous conditions. However, for most research applications, they would be used separately to characterize each compound's receptor engagement profile independently. Researchers should validate any combination protocol against their specific experimental goals.
What receptor subtypes do MT-2 and PT-141 target in research models?
MT-2 shows activity at MC1R, MC3R, MC4R, and MC5R in binding studies, making it a broad melanocortin agonist useful for studying the system holistically. PT-141 has a somewhat similar profile with research interest particularly focused on MC3R and MC4R involvement. Both compounds have been used in studies examining pigmentation (MC1R), central appetite regulation (MC4R), and inflammatory modulation (MC3R) in preclinical animal models.
Is a clear solution after reconstitution normal for MT-2 and PT-141?
Yes. Unlike GHK-Cu, which has a characteristic blue-green color from its copper ion, reconstituted MT-2 and PT-141 in BAC water produce clear, colorless solutions. Any cloudiness, visible particulate matter, or unexpected coloration should be treated as a warning sign of contamination or degradation, and the preparation should be discarded.
How do I verify my reconstituted MT-2 or PT-141 has not degraded due to light exposure?
Visual inspection alone is not a reliable indicator of photo-degradation, as oxidized or structurally modified peptide solutions may remain visually clear and colorless. Researchers requiring confirmation of peptide integrity after reconstitution and storage should use analytical methods such as high-performance liquid chromatography (HPLC) or mass spectrometry to verify molecular integrity. For most routine research applications, strict adherence to light protection protocols during all handling steps is the primary mitigation strategy.
What is the difference between MT-2 and PT-141 in terms of research applications?
MT-2 has broader melanocortin receptor activity (including stronger MC1R engagement) and has been more extensively used in pigmentation biology research. PT-141 is often preferred when research focus is specifically on central melanocortin pathways, particularly MC4R-mediated systems. Both compounds are appropriate preclinical research tools; the choice depends on the specific receptor subtypes and biological pathways under investigation.
At what concentration should MT-2 be reconstituted for rodent model research?
Published preclinical research using MT-2 in rodent models has typically used stock concentrations of 1.0 to 2.0 mg/mL in aqueous vehicles including BAC water. Specific dosing volumes and concentrations should be determined based on your experimental protocol, animal model body weight, intended dose per kilogram, and delivery route. Working from the established literature in your specific model system is strongly recommended.
Peer-Reviewed Citations
- Dorr RT, Lines R, Levine N, Brooks C, Xiang L, Hruby VJ, Hadley ME. "Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study." Life Sciences. 1996;58(20):1777-1784.
- Van der Ploeg LH, Martin WJ, Howard AD, Bhatt RS, Roland BL, Wilson S, Bolon B, Goulet M, Trumbauer M, Brown MS, Goldstein JL, Chen HY. "A role for the melanocortin 4 receptor in sexual function." Proceedings of the National Academy of Sciences. 2002;99(17):11381-11386.
- Wikberg JE, Muceniece R, Mandrika I, Prusis P, Lindblom J, Post C, Skottner A. "New aspects on the melanocortins and their receptors." Pharmacological Research. 2000;42(5):393-420.
- Cone RD. "Anatomy and regulation of the central melanocortin system." Nature Neuroscience. 2005;8(5):571-578.
- Hadley ME, Dorr RT. "Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization." Peptides. 2006;27(4):921-930.
- Hruby VJ, Lu D, Sharma SD, Castrucci AL, Kesterson RA, al-Obeidi FA, Hadley ME, Cone RD. "Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-c[Asp5, D-Phe7, Lys10]alpha-MSH-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors." Journal of Medicinal Chemistry. 1995;38(18):3454-3461.
Final Disclaimer: All compounds discussed are research chemicals not approved by the FDA for human or veterinary use. All content here is for scientific and educational reference only. Palmetto Peptides sells these products exclusively for in vitro and preclinical laboratory research.
Authored by the Palmetto Peptides Research Team | Last Updated: May 18, 2026